Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study.

alternative medicine. Prev Med 2002;35:166-73. 2 Eisenberg D, Davis R, Ettner S, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998;280:1569-75. 3 Mombelli B, Gismondo MR. The use of probiotics in medical practice. Int J Antimicrob Agents 2000;16:531-6. 4 Pirotta M, Gunn J, Chondros P. “Not thrush again!” Women’s experience of post-antibiotic vulvovaginitis.Med J Aust 2003;179:43-6. 5 Nyirjesy P, Weitz M, Grody T, Lorber B. Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol 1997;90:50-3. 6 Chapple A,Hassell K, Nicolson M,Cantrill J. ‘You don’t really feel you can function normally’: women’s perceptions and personal management of vaginal thrush. J Reprod Infant Psychol 2000;18:309-19. 7 Pizzorno L, Pizzorni J, Murray M. Natural medicine instructions for patients. Edinburgh: Churchill Livingstone, 2002. 8 Bluestein D, Rutledge C, Lumsden L. Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991; 11:319-26. 9 Pirotta M, Gunn J, Chondros P, Grover S, Hurley S, Garland S. Study protocol. The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]. BMC Fam Pract 2004;5:5. 10 O’Brien P, Fleming T. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56. 11 Nelson D, Bellamy S, Gray T, Nachamkin I. Self-collected versus providercollected vaginal swabs for the diagnosis of bacterial vaginosis: an assessment of validity and reliability. J Clin Epidemiol 2003;56:862-6. 12 Pocock S. When to stop a clinical trial. BMJ 1992;305:235-6. 13 Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora.Rev Infect Dis 1990;12:856-72. 14 McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 1993;6:251-64. 15 Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991;164:94-100. 16 Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11. 17 Sobel JD, ChaimW. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 1996;34:2497-9. 18 Fidel PL Jr. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models. Int Rev Immunol 2002;21:515-48.